Nootropics Index - Save on smarter supplements
Nootropics>Polysaccharides, amino sugars & glycosaminoglycans>D-Glucosamine
Polysaccharides, amino sugars & glycosaminoglycans

D-Glucosamine

D-glucosamine (2-amino-2-deoxy-D-glucopyranose)

D-glucosamine is an amino sugar sold mainly as glucosamine sulfate or hydrochloride, sometimes in joint-formula blends. Human research is form-specific and mixed in osteoarthritis contexts; the clinical sources reviewed here do not establish direct effects on focus, memory, mood, or productivity. Compare the labeled form, active amount, and like-for-like price before judging an offer.

Isolated CompoundClinical ResearchMixed EvidenceForm Dependent EvidenceLow Risk ProfileGi Side EffectsPregnancy Caution
Updated July 2026/5 min read/9 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

D-glucosamine is an amino sugar

1

D-glucosamine is the D form of glucosamine, also called 2-amino-2-deoxy-D-glucopyranose. This chemical identity is distinct from the sulfate, hydrochloride, and blend formulations shown in product listings.

What the evidence does and does not show2
Human research focuses on glucosamine formulations in osteoarthritis, where results are inconsistent and formulation-dependent. That evidence does not establish focus, memory, mood, or productivity effects.
02

Names, aliases and forms

Common Namesglucosamine; chitosamine
Chemical Name2-amino-2-deoxy-D-glucose
Cas Number3416-24-8
Pubchem Cid439213
Salt Formsglucosamine sulfate; glucosamine hydrochloride
03

Mechanisms of action

Amino-sugar biology is not a cognitive mechanism

2

Glucosamine is a building block for glycosaminoglycans, which helps explain its joint-product context. That chemistry is not direct evidence for neurotransmitter, alertness, or learning effects.

04

Potential effects and evidence map

For cognitive use, the clinical sources reviewed here do not establish direct human effects. They instead examine glucosamine sulfate or hydrochloride in osteoarthritis contexts, where study findings and guideline positions are mixed and formulation-dependent.

Effect domainMagnitudeGrade
Cellular / long-term brain support1
UnknownConfidence: Low

Amino-sugar biology does not establish a brain-support benefit for D-glucosamine.

Note Mechanistic context is not evidence of a cognitive effect.

0/5
D
Focus / attention2
UnknownConfidence: High

The cited human sources do not establish D-glucosamine effects on focus or attention.

Note Human research is centered on non-cognitive outcomes.

0/5
E
Memory / learning2
UnknownConfidence: High

The cited human sources do not establish D-glucosamine effects on memory or learning.

Note Joint-formulation studies do not answer a memory claim.

0/5
E
Mood / wellbeing2
UnknownConfidence: High

The cited human sources do not establish a mood or wellbeing effect.

Note Do not transfer joint-study findings to mood claims.

0/5
E
Physical energy / endurance4
UnknownConfidence: Medium

Joint-study outcomes do not establish physical-energy or endurance effects.

Note The cited joint-study sources do not assess endurance.

0/5
E
05

Typical dosages and timing

Large-trial amount31500 mg/day

The linked large trial used this amount of glucosamine hydrochloride. It records a study protocol, not an individual dose, product equivalence, or a suggested cycle.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
No supported nootropic timing2

The cited human sources do not establish an acute focus, memory, or mood onset for D-glucosamine. Joint-formulation research used repeated-dose study windows, but a study duration is not an effect duration or a suggested cycle.

07

Safety, side effects and risk profile

Blood-glucose context2
NCCIH notes that glucosamine may increase blood glucose in some people. This is a population-specific consideration and does not establish a high base risk for generally healthy adults.
Emerging dementia-specific signal9
A 2026 study reported worse social-memory performance in an Alzheimer's-disease mouse model and EHR associations with worse survival in Alzheimer's-related dementia and more MCI-to-ADRD conversion among recorded glucosamine users. It cannot prove causation in people or establish a risk for healthy adults, but it is relevant preliminary context for readers with MCI or dementia.
Pregnancy / lactation caution2
Confidence: Medium

Little is known about glucosamine safety during pregnancy or breastfeeding.

Note Limited data are an evidence gap, not a high base-risk rating for healthy adults.

2/5
D
GI discomfort8
Confidence: Medium

A systematic review found no increase in gastrointestinal adverse events with glucosamine sulfate versus placebo.

Note That finding is formulation-specific and does not establish tolerability for every product.

1/5
C
Interaction risk7
Confidence: Medium

Glucosamine may increase warfarin effects and the risk of serious bruising or bleeding.

Note The documented caution is specific to anticoagulants such as warfarin, not every medicine.

3/5
C
Evidence uncertainty2
Confidence: High

Human findings vary by formulation, study design, and outcome; cognitive claims lack a direct evidence base.

Note Compare the actual formulation and outcome rather than pooling all glucosamine products.

1/5
C
Legal / regulatory risk6
Confidence: High

U.S. dietary-supplement regulation differs from drug approval and does not determine status in other jurisdictions.

Note The public legal note is explicitly scoped to the United States as of 2026.

1/5
C
Overall safety signal8No major signal

A systematic review of placebo-controlled trials did not identify more total or gastrointestinal adverse events with glucosamine sulfate than placebo. This does not establish safety for every formulation or population.

08

Interactions and cautions

Specific interaction7

Glucosamine may increase the effects of warfarin and the risk of serious bruising or bleeding. The cited source identifies warfarin specifically; it does not establish a blanket interaction with every medicine.

09

Legal and regulatory status

United States, as of 20266

In the United States, FDA does not approve dietary supplements for safety, effectiveness, or labeling before sale. This describes the U.S. framework; it is not product-specific FDA approval and does not state rules for other jurisdictions.

10

How it compares

Form matters3

The linked large trial used glucosamine hydrochloride. Results from sulfate, hydrochloride, and combination products should not be pooled casually when comparing evidence or price.

11

Practical buying and quality notes

  • Use the Supplement Facts panel to identify the named salt, active amount, serving size, and other ingredients. Per-unit normalization is an editorial comparison method, not an FDA requirement: compare powders by price per gram and capsules by price per capsule, keeping forms separate.6
12

FAQ

Is D-glucosamine a nootropic?

2

The cited human sources do not establish direct effects on focus, memory, mood, or productivity. Most human research concerns glucosamine formulations in osteoarthritis and has mixed findings.

What dose appears in research?

3

The linked large trial used 1,500 mg/day of glucosamine hydrochloride. That study protocol is not a personalized recommendation; check which salt or blend the label names.

Does form matter?

2

Yes. Sulfate, hydrochloride, and multi-ingredient products should not be pooled casually when comparing price, dose context, or evidence.

What safety context should buyers compare?

2

Pregnancy and breastfeeding safety data are limited. NCCIH also notes that glucosamine may increase blood glucose in some people; these are population-specific considerations rather than a general high-risk rating for healthy adults.

13

References

  1. PubChem Compound Summary for CID 439213, D-Glucosamine. National Center for Biotechnology Information.
  2. National Center for Complementary and Integrative Health. Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know.
  3. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795-808.
  4. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675.
  5. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162.
  6. U.S. Food and Drug Administration. FDA 101: Dietary Supplements.
  7. National Center for Complementary and Integrative Health. Know the Science: How Medications and Supplements Can Interact.
  8. Honvo G, Reginster J-Y, Rabenda V, et al. Safety of symptomatic slow-acting drugs for osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs & Aging. 2019;36(Suppl 1):65-99.
  9. Hawkinson TR, Liu Z, Ribas RA, et al. Hyperglycosylation is a metabolic driver of Alzheimer's disease. Nat Metab. 2026;8(6):1410-1425.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.